Each film-coated tablet of SLIMIOGIC contains 9 mg of orforglipron, a GLP-1 receptor agonist.

Each film-coated tablet of SLIMIOGIC contains 5.5 mg of orforglipron, a GLP-1 receptor agonist.

Each film-coated tablet of SLIMIOGIC contains 2.5 mg of orforglipron, a GLP-1 receptor agonist.

Each film-coated tablet of SLIMIOGIC contains 0.8 mg of orforglipron, a GLP-1 receptor agonist.

Each film-coated tablet contains:Semaglutide 14 mg
Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1.Semaglutide acts as a GLP-1 receptor agonist that sele ctively binds to and activates the GLP-1 receptor, the target for native GLP-1.

Each film-coated tablet contains:Semaglutide 3mg
Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1.Semaglutide acts as a GLP-1 receptor agonist that sele ctively binds to and activates the GLP-1 receptor, the target for native GLP-1.Traceability

In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.